Skip to main content

Table 5 Univariate analysis of ERCP-related adverse events in patients with and without EBS, calculated by ERCP sessions

From: Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma

Adverse events

With EBSa

Without EBS

P-value

All adverse events

12.0% (33/275)

21.7% (41/189)

0.005

Pancreatitis

Mild

Moderate

Severe

0.4% (1/275)

0.4% (1/275)

13.8% (26/189)

2.6% (5/189)

1.1% (2/189)

 < 0.001

Cholangitis

10.9% (30/275)

3.7% (7/189)

0.005

Cholecystitis

0.4% (1/275)

0.407

  1. EBS endoscopic biliary stenting
  2. aPatients who had EBS prolapse and underwent PTBD placement were excluded